U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations
Posted inAbbVie Inc Amgen Inc AstraZeneca PLC Biden, Joseph R Jr Boehringer Ingelheim GmbH Bristol Myers Squibb Company Drugs (Pharmaceuticals) Eli Lilly and Company Harris, Kamala D Inflation Reduction Act of 2022 Johnson & Johnson Medicare Merck & Company Inc Novartis AG Novo Nordisk A/S Pfizer Inc Presidential Election of 2024 Trump, Donald J United States Politics and Government

U.S. to Announce Prices for First Drugs Picked for Medicare Negotiations

The Biden administration said it would have saved $6 billion had the new prices been in effect last year.
Hot Summer Threatens Efficacy of Mail-Order Medications
Posted inCIGNA Corporation CVS Caremark Corporation Delivery Services Drugs (Pharmaceuticals) Express Scripts Inc Food and Drug Administration Heat and Heat Waves Insulin OptumRx Inc Regulation and Deregulation of Industry Weather your-feed-healthcare your-feed-science

Hot Summer Threatens Efficacy of Mail-Order Medications

The temperatures inside delivery trucks can reach twice the recommended threshold, but federal rules on drug storage conditions do not apply to the booming world of mail-order delivery.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Posted inClinical Trials Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration LSD (Lysergic Acid Diethylamide) Lykos Therapeutics Mental Health and Disorders Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychology and Psychologists Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.
Veterans and Lawmakers Lobby for Approval of MDMA Therapy
Posted inBergman, Jack (1947- ) Clinical Trials Depression (Mental) Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration House of Representatives Institute for Clinical and Economic Review LSD (Lysergic Acid Diethylamide) Lykos Therapeutics Mental Health and Disorders Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

Veterans and Lawmakers Lobby for Approval of MDMA Therapy

The F.D.A. is poised to rule on the therapeutic use of the club drug Ecstasy, a potential watershed moment in the nascent field of psychedelic medicine.